By analysing plasma samples of patients with angiographically documented CAD, we confirmed its potential role as a marker for cardiovascular disease as well as its correlation with the severity of CAD, which may be in part driven by LCN2-activated macrophages. The gene discussed is LCN2; the disease is coronary artery disorder.